Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion type Assertion NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_head.
- NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion description "[The androgen receptor (AR) and the phosphoinositide 3-kinase (PI3K)/protein kinase B/mammalian target of rapamycin (mTOR) signaling are two of the major proliferative pathways in a number of tissues and are the main therapeutic targets in various disorders, including prostate cancer (PCa).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_provenance.
- NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion evidence source_evidence_literature NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_provenance.
- NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion SIO_000772 23798432 NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_provenance.
- NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion wasDerivedFrom befree-20140225 NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_provenance.
- NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_assertion wasGeneratedBy ECO_0000203 NP226898.RA-4krniaCvUNIppBxrYiy8LMBh2oHYoEu_3xCQB1Qmc0130_provenance.